Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
General Dermatology
What is the process for purchasing and billing Medicare for biologics used in the treatment of psoriasis?
Related Questions
What treatment do you recommend for painful large plaques of leiomyomas on the back of a patient with HLRCC syndrome when lesions are too large for excision?
How would you manage a patient with profound hyperpigmentation of the face and neck which is attributed to a post-COVID vaccine reaction?
Would you start glycopyrrolate in elderly population and how do you counsel the patient?
How often, and why, do you complete disability forms for dermatologic patients?
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?
Do you pursue a cardiac evaluation in all patients with an excised cutaneous myxoma?
How would you manage a patient with nonspecific clinical symptoms and pathology consistent with spongiotic and psoriasiform dermatitis other than oral JAK inhibitors?
What orals or biologics do you reach for in a child with recalcitrant inverse psoriasis in the groin who has tried and failed topical including steroids, pimecrolimus, zoryve, ketoconazole, and tacrolimus?
How would you approach treatment failures with squamous cell carcinoma-keratoacanthoma-type lesions that did not respond to a standard SRT regimen after many sessions?
In the era of targeted therapies, are there any specific cytokines that help guide therapy?
